Developed using STEERLife’s proprietary FragMelt continuous processing platform, the approval marks a major breakthrough in pharmaceutical manufacturing
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
The therapy is mutation-agnostic and aims to overcome limitations of existing EGFR-targeting drugs by concentrating degradation in tumors while sparing healthy tissue
Subscribe To Our Newsletter & Stay Updated